Hsbc Holdings PLC Has $3.32 Million Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Hsbc Holdings PLC increased its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 221.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 42,682 shares of the company's stock after buying an additional 29,398 shares during the quarter. Hsbc Holdings PLC owned about 0.09% of Prestige Consumer Healthcare worth $3,324,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the company. JPMorgan Chase & Co. lifted its stake in Prestige Consumer Healthcare by 3.2% during the third quarter. JPMorgan Chase & Co. now owns 272,255 shares of the company's stock worth $19,630,000 after purchasing an additional 8,533 shares during the last quarter. Avior Wealth Management LLC raised its stake in Prestige Consumer Healthcare by 1,570.7% during the fourth quarter. Avior Wealth Management LLC now owns 8,554 shares of the company's stock worth $668,000 after acquiring an additional 8,042 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in Prestige Consumer Healthcare by 5.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company's stock valued at $49,667,000 after acquiring an additional 33,844 shares during the period. Norges Bank bought a new position in shares of Prestige Consumer Healthcare during the fourth quarter valued at approximately $40,009,000. Finally, Barclays PLC boosted its position in Prestige Consumer Healthcare by 346.3% during the 3rd quarter. Barclays PLC now owns 92,444 shares of the company's stock valued at $6,665,000 after purchasing an additional 71,730 shares during the period. 99.95% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, SVP Mary Beth Fritz sold 1,678 shares of the business's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.00, for a total value of $151,020.00. Following the transaction, the senior vice president now directly owns 17,157 shares of the company's stock, valued at $1,544,130. The trade was a 8.91 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research firms have issued reports on PBH. StockNews.com raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Tuesday, April 29th. DA Davidson upped their price objective on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Oppenheimer upped their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research note on Thursday, February 13th. Canaccord Genuity Group lifted their price target on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Finally, Royal Bank of Canada raised their target price on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a "sector perform" rating in a research note on Friday, March 21st. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $93.33.

Prestige Consumer Healthcare Stock Down 0.7 %

Shares of PBH stock traded down $0.57 during trading on Monday, hitting $83.62. 82,029 shares of the company were exchanged, compared to its average volume of 348,645. Prestige Consumer Healthcare Inc. has a twelve month low of $62.35 and a twelve month high of $90.04. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. The firm has a market capitalization of $4.14 billion, a price-to-earnings ratio of 19.60, a P/E/G ratio of 2.69 and a beta of 0.47. The business's 50-day simple moving average is $83.27 and its 200 day simple moving average is $81.03.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, beating analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. As a group, analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.